Beclometasone dipropionato topico nelle malattie infiammatorie intestinali: Risultati di un'indagine multicentrica

M. Borzio; F. Borzio; G. Milano; M. Biraghi; L. Cestari; P. Ravelli; R. de Franchis; M. Vecchi; G. Minoli; A. Prada; M. Curzio; M. Galeone; G. I. Toti; D. Cacioli; J. Megevand

Beclometasone dipropionato topico nelle malattie infiammatorie intestinali: Risultati di un'indagine multicentrica

Translated title of the contribution: Topical beclomethasone dipropionate (BDP) in intestinal inflammatory diseases: The results of a multicentre trial

M. Borzio, F. Borzio, G. Milano, M. Biraghi, L. Cestari, P. Ravelli, R. de Franchis, M. Vecchi, G. Minoli, A. Prada, M. Curzio, M. Galeone, G. I. Toti, D. Cacioli, J. Megevand

IRCCS Policlinico San Donato

Research output: Contribution to journal › Article › peer-review

Abstract

The authors assessed the efficacy and tolerability of BDP in an open protocol using rectal enemas and suppositories and in a double-blind protocol vs mesalazine using rectal enemas. A total of 47 patients suffering from ulcerous rectocolitis were enrolled in the study and treated for 42 days while undergoing endoscopic, histologic and clinical controls. In conclusion, the authors affirm that BDP may represent a useful new therapeutic instrument in the treatment of slight to moderately severe forms of inflammatory intestinal disease.

Translated title of the contribution	Topical beclomethasone dipropionate (BDP) in intestinal inflammatory diseases: The results of a multicentre trial
Original language	Italian
Pages (from-to)	59-73
Number of pages	15
Journal	Minerva Gastroenterologica e Dietologica
Volume	45
Issue number	1
Publication status	Published - 1999

ASJC Scopus subject areas

Gastroenterology

Cite this

Borzio, M., Borzio, F., Milano, G., Biraghi, M., Cestari, L., Ravelli, P., de Franchis, R., Vecchi, M., Minoli, G., Prada, A., Curzio, M., Galeone, M., Toti, G. I., Cacioli, D., & Megevand, J. (1999). Beclometasone dipropionato topico nelle malattie infiammatorie intestinali: Risultati di un'indagine multicentrica. Minerva Gastroenterologica e Dietologica, 45(1), 59-73.

@article{0576dd16c7e846e5bcb662ba55e0f21b,

title = "Beclometasone dipropionato topico nelle malattie infiammatorie intestinali: Risultati di un'indagine multicentrica",

abstract = "The authors assessed the efficacy and tolerability of BDP in an open protocol using rectal enemas and suppositories and in a double-blind protocol vs mesalazine using rectal enemas. A total of 47 patients suffering from ulcerous rectocolitis were enrolled in the study and treated for 42 days while undergoing endoscopic, histologic and clinical controls. In conclusion, the authors affirm that BDP may represent a useful new therapeutic instrument in the treatment of slight to moderately severe forms of inflammatory intestinal disease.",

keywords = "Beclomethasone dipropionate, Inflammatory, Intestinal diseases, Mesalazine, Topical therapy",

author = "M. Borzio and F. Borzio and G. Milano and M. Biraghi and L. Cestari and P. Ravelli and {de Franchis}, R. and M. Vecchi and G. Minoli and A. Prada and M. Curzio and M. Galeone and Toti, {G. I.} and D. Cacioli and J. Megevand",

year = "1999",

language = "Italian",

volume = "45",

pages = "59--73",

journal = "Minerva Gastroenterologica",

issn = "0026-4776",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "1",

}

TY - JOUR

T1 - Beclometasone dipropionato topico nelle malattie infiammatorie intestinali

T2 - Risultati di un'indagine multicentrica

AU - Borzio, M.

AU - Borzio, F.

AU - Milano, G.

AU - Biraghi, M.

AU - Cestari, L.

AU - Ravelli, P.

AU - de Franchis, R.

AU - Vecchi, M.

AU - Minoli, G.

AU - Prada, A.

AU - Curzio, M.

AU - Galeone, M.

AU - Toti, G. I.

AU - Cacioli, D.

AU - Megevand, J.

PY - 1999

Y1 - 1999

N2 - The authors assessed the efficacy and tolerability of BDP in an open protocol using rectal enemas and suppositories and in a double-blind protocol vs mesalazine using rectal enemas. A total of 47 patients suffering from ulcerous rectocolitis were enrolled in the study and treated for 42 days while undergoing endoscopic, histologic and clinical controls. In conclusion, the authors affirm that BDP may represent a useful new therapeutic instrument in the treatment of slight to moderately severe forms of inflammatory intestinal disease.

AB - The authors assessed the efficacy and tolerability of BDP in an open protocol using rectal enemas and suppositories and in a double-blind protocol vs mesalazine using rectal enemas. A total of 47 patients suffering from ulcerous rectocolitis were enrolled in the study and treated for 42 days while undergoing endoscopic, histologic and clinical controls. In conclusion, the authors affirm that BDP may represent a useful new therapeutic instrument in the treatment of slight to moderately severe forms of inflammatory intestinal disease.

KW - Beclomethasone dipropionate

KW - Inflammatory

KW - Intestinal diseases

KW - Mesalazine

KW - Topical therapy

UR - http://www.scopus.com/inward/record.url?scp=0032977482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032977482&partnerID=8YFLogxK

M3 - Articolo

C2 - 16498317

AN - SCOPUS:0032977482

SN - 0026-4776

VL - 45

SP - 59

EP - 73

JO - Minerva Gastroenterologica

JF - Minerva Gastroenterologica

IS - 1

ER -

Beclometasone dipropionato topico nelle malattie infiammatorie intestinali: Risultati di un'indagine multicentrica

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this